Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

Similar articles for PubMed (Select 17913587)

1.

The role of Ras signaling in lupus T lymphocytes: biology and pathogenesis.

Mor A, Philips MR, Pillinger MH.

Clin Immunol. 2007 Dec;125(3):215-23. Epub 2007 Oct 3. Review.

PMID:
17913587
2.

T-cell signaling abnormalities in human systemic lupus erythematosus.

Nambiar MP, Krishnan S, Tsokos GC.

Methods Mol Med. 2004;102:31-47.

PMID:
15286379
3.

Control of T lymphocyte signaling by Ly108, a signaling lymphocytic activation molecule family receptor implicated in autoimmunity.

Zhong MC, Veillette A.

J Biol Chem. 2008 Jul 11;283(28):19255-64. doi: 10.1074/jbc.M800209200. Epub 2008 May 15.

4.

T- and B-cell abnormalities in systemic lupus erythematosus.

Nagy G, Koncz A, Perl A.

Crit Rev Immunol. 2005;25(2):123-40. Review.

PMID:
15952933
5.

TCR zeta-chain abnormalities in human systemic lupus erythematosus.

Nambiar MP, Krishnan S, Warke VG, Tsokos GC.

Methods Mol Med. 2004;102:49-72.

PMID:
15286380
6.

Rai acts as a negative regulator of autoimmunity by inhibiting antigen receptor signaling and lymphocyte activation.

Savino MT, Ortensi B, Ferro M, Ulivieri C, Fanigliulo D, Paccagnini E, Lazzi S, Osti D, Pelicci G, Baldari CT.

J Immunol. 2009 Jan 1;182(1):301-8.

7.

Altered T and B lymphocyte signaling pathways in lupus.

Peng SL.

Autoimmun Rev. 2009 Jan;8(3):179-83. doi: 10.1016/j.autrev.2008.07.040. Epub 2008 Aug 20. Review.

PMID:
18721908
8.

Nitric oxide, chronic inflammation and autoimmunity.

Nagy G, Clark JM, Buzás EI, Gorman CL, Cope AP.

Immunol Lett. 2007 Jul 31;111(1):1-5. Epub 2007 May 25. Review.

PMID:
17568690
9.

Lupus-like autoimmunity caused by defects in T-cell signal transduction.

King PD.

Curr Opin Investig Drugs. 2004 May;5(5):517-23. Review.

PMID:
15202725
11.

Changes in the T cell receptor macromolecular signaling complex and membrane microdomains during T cell development and activation.

Leitenberg D, Balamuth F, Bottomly K.

Semin Immunol. 2001 Apr;13(2):129-38. Review.

PMID:
11308296
12.

Immune cell biochemical abnormalities in systemic lupus erythematosus.

Liossis SN, Vassilopoulos D, Kovacs B, Tsokos GC.

Clin Exp Rheumatol. 1997 Nov-Dec;15(6):677-84. Review.

PMID:
9444427
13.

Costimulatory molecules as immunotherapeutic targets in systemic lupus erythematosus.

Foell J, Mittler RS.

Springer Semin Immunopathol. 2006 Oct;28(2):153-62. Epub 2006 Sep 2. Review.

PMID:
16951932
14.
15.

T lymphocytes in systemic lupus erythematosus: an update.

Kyttaris VC, Tsokos GC.

Curr Opin Rheumatol. 2004 Sep;16(5):548-52. Review.

PMID:
15314492
16.

Genetics of T cell defects in lupus.

Chen YF, Morel L.

Cell Mol Immunol. 2005 Dec;2(6):403-9. Review.

17.

Dissecting the molecular mechanisms of TCR zeta chain downregulation and T cell signaling abnormalities in human systemic lupus erythematosus.

Nambiar MP, Juang YT, Krishnan S, Tsokos GC.

Int Rev Immunol. 2004 May-Aug;23(3-4):245-63. Review.

PMID:
15204087
18.

RasGRF2, a guanosine nucleotide exchange factor for Ras GTPases, participates in T-cell signaling responses.

Ruiz S, Santos E, Bustelo XR.

Mol Cell Biol. 2007 Dec;27(23):8127-42. Epub 2007 Oct 8.

19.

Control of lymphocyte development and activation by negative regulatory transmembrane adapter proteins.

Simeoni L, Lindquist JA, Smida M, Witte V, Arndt B, Schraven B.

Immunol Rev. 2008 Aug;224:215-28. doi: 10.1111/j.1600-065X.2008.00656.x. Review.

PMID:
18759929
20.

T cells in the pathogenesis of systemic lupus erythematosus.

Hoffman RW.

Clin Immunol. 2004 Oct;113(1):4-13. Review.

PMID:
15380523
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk